Suchergebnisse - "Cappello, Maria"

PubPharm (11)

1

Two-year effectiveness and safety of golimumab in ulcerative colitis : An IG-IBD study

enthalten in: United European gastroenterology journal | 2021

von Pugliese, D. | Privitera, G. | Rogai, F. | +29

2

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +20

3

Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2020

von Bossa, F. | Biscaglia, G. | Valvano, M. | +32

4

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients : Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

enthalten in: Drugs & aging | 2020

von Porcari, S. | Viola, A. | Orlando, A. | +22

5

Inflammatory Bowel Disease Onset During Secukinumab Treatment : Real Concern or Just an Expression of Dysregulated Immune Response?

enthalten in: Clinical drug investigation | 2019

von Fries, W. | Belvedere, A. | Cappello, M. | +2

6

Use of biosimilars in inflammatory bowel disease : a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Fiorino, G. | Caprioli, F. | Daperno, M. | +92

7

The PROSIT Cohort of Infliximab Biosimilar in IBD : A Prolonged Follow-up on the Effectiveness and Safety Across Italy

enthalten in: Inflammatory bowel diseases | 2019

von Armuzzi, A. | Fiorino, G. | Variola, A. | +30

8

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Renna, S. | Mocciaro, F. | Ventimiglia, M. | +18

9

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis : early and late outcome and predictors of colectomy

enthalten in: Journal of Crohn's & colitis | 2014

von Monterubbianesi, R. | Aratari, A. | Armuzzi, A. | +16

CommentIn: J Crohns Colitis. 2014 Oct;8(10):1327-8. - PMID 24631323

10

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2011

von Cottone, M. | Kohn, A. | Daperno, M. | +16

CommentIn: Inflamm Bowel Dis. 2012 Mar;18(3):594-5. - PMID 21674726